Investigating the method of selection of background pixel values for the calibration of EBT-XD film dosimetry

Abstract

Purpose: This study investigates three different calibration methods for the selection of background pixel intensity.

Methods: Film-by-Film (FBF) Method: Each film serves as its own control. Batch-by-Film (BBF) Method: A single film is used as a control for all calibration films. Generic (GEN) Method: A generic value (65535) is used as the background pixel value for all calibration films. Three calibration curves were established for the red, green, blue, and RGB channels, and the Radbard NIH (image) curve-fitting model was used to predict the dose. Sensitivity at different dose levels was quantified by calculating the first derivative of each color channel.

Results: The GEN method exhibited a difference of up to 6% between the predicted and delivered doses below 2 Gy. The changes in optical density when using the GEN method differed significantly (p<0.0001) from those of the FBF and BBF methods. In the dose range 5–30 Gy, the percentage difference between the predicted and delivered doses for the FBF, BBF, and GEN methods was within 2%. Both the red and green channels demonstrated higher sensitivity than the blue channel over the dose range of 2–30 Gy.

Conclusions: The FBF method is more accurate than the BBF and GEN methods because it accounts for inter-film variations. The Radbard NIH (image) curve-fitting function proved suitable for predicting the dose for all the three calibration methods.

Keywords

Film dosimetry / EBT-XD film / Calibration curve

References

[1] Fiandra C, Fusella M, Giglioli FR, et al. Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs. Med Phys. 2013;40(8):082105.

[2] Stella G, Cavalli N, Bonanno E, et al. SBRT/SRS patient-specific QA using GAFchromicTM EBT3 and FilmQATM Pro software. J Radiosurg SBRT. 2022;8(1):37-45.

[3] Yan G, Liu C, Simon TA, Peng LC, Fox C, Li JG. On the sensitivity of patient-specific IMRT QA to MLC positioning errors. J Appl Clin Med Phys. 2009;10(1):120-128.

[4] Wen N, Lu S, Kim J, et al. Precise film dosimetry for stereotactic radiosurgery and stereotactic body radiotherapy quality assurance using Gafchromic™EBT3 films. Radiat Oncol. 2016;11(1):1-1.

[5] Calvo-Ortega JF, Moragues-Femenía S, Laosa-Bello C, San José-Maderuelo S, Casals-Farran J. A closer look at the conventional Winston-Lutz test: Analysis in terms of dose. Rep Pract Oncol Radiother. 2019;24(5):421-427.

[6] Bernchou U, Christiansen RL, Bertelsen A, et al. End-to-end validation of the geometric dose delivery performance of MR linac adaptive radiotherapy. Phys Med Biol. 2021;66(4):045034.

[7] Boh Lim S, Tyagi N, Subashi E, Liang J, Chan M. An evaluation of the use of EBT-XD film for SRS/SBRT commissioning of a 1.5 Tesla MR-Linac system. Phys Med. 2022;96:9-17.

[8] Parveen N, Ramachandran P, Seshadri V, Perrett B, Fielding A. Comparison and validation of multiple detectors againstmonte carlo simulation for the use of small-field dosimetry. JMedPhys. 2022;47(3):235-242.

[9] Fokou M, Hasford F, Ndontchueng MM, et al. In-vivo dosimetry with EBT-3 gafchromic films and thermoluminescent dosimeters in breast cancer radiotherapy treatments. Healt Tech. 2023;13(4):585-600.

[10] Niroomand-Rad A, Chiu-Tsao ST, Grams MP, et al. Report of AAPM task group 235 radiochromic film dosimetry: an update to TG-55. Med phys. 2020;47(12):5986-6025.

[11] Ashland ISP Inc. Gafchromic dosimetry media, type EBT-XD. Wilmington, DE: Ashland ISP Inc.; 2015. Availablefrom: www.ashland.com/Ashland/Static/Documents/ASI/Advanced%20Materials/EBTXD_Specifications.pdf

[12] Grams MP, Gustafson JM, Long KM, de los Santos LE. initial characterization of the new EBT-XD Gafchromic film. Med Phys. 2015;42(10):5782-5786.

[13] León-Marroquín EY, Mulrow D, Darafsheh A, Khan R. Response characterization of EBT-XD radiochromic films inmegavoltage photon and electron beams. Med phys. 2019;46(9):4246-4256.

[14] Miura H, Ozawa S, Hosono F, et al. Gafchromic EBT-XD film: Dosimetry characterization in high-dose, volumetric-modulated arc therapy. J Appl Clin Med Phys. 2016;17(6):312-322.

[15] Khachonkham S, Dreindl R, Heilemann G, et al. Characteristic of EBTXD and EBT3 radiochromic film dosimetry for photon and proton beams. Phys Med Biol. 2018;63(6):065007.

[16] Santos T, Ventura T, Capela M, Mateus J, Lopes MDC. A protocol for absolute dose verification of SBRT/SRS treatment plans using Gafchromic™EBT-XD films. Phys Med. 2021;82:150-157.

[17] Lewis DF, Chan MF. Technical Note: On GAFChromic EBT-XD film and the lateral response artifact. Med Phys. 2016;43(2):643-649.

[18] Guan F, Wang X, Yang M, et al. Dosimetric response of Gafchromic™ EBT-XD film to therapeutic protons. Precis Radiat Oncol. 2023;7(1):15-26.

[19] International Atomic Energy Agency. Absorbed Dose Determination in External Beam Radiotherapy. Technical Reports Series No. 398, Vienna: IAEA; 2000.

[20] Marroquin EY, Herrera González JA, Camacho López MA, Barajas JE, García-Garduño OA. Evaluation of the uncertainty in an EBT3 film dosimetry system utilizing net optical density. J Appl Clin Med Phys. 2016;17(5):466-481.

[21] Perles LA, Mirkovic D, Anand A, Titt U, Mohan R. LET dependence of the response of EBT2 films in proton dosimetrymodeled as a bimolecular chemical reaction. Phys Med Biol. 2013;58(23):8477-8491.

RIGHTS & PERMISSIONS

2024 The Author(s). Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.